Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-03-15
1993-07-20
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 514 15, 530324, 530325, 530326, 530327, 530328, 530806, A61K 3700, C07K 500
Patent
active
052293645
ABSTRACT:
A polypeptide of the formula (SEQ ID NO 24): X-Glu-Thr-Gly-Gln-Glu-Thr-Ala-Tyr-Phe-Ile-Leu-Lys-Leu-Ala-Gly-Arg-Trp-Pro- Val-Lys-Z wherein X is a chain of from 1 to 20 amino acid residues or an amino-terminal group and Z is a chain of from 1 to 20 amino acid residues or a carboxy-terminal group. The polypeptide immunologically mimics HIV endonuclease (p 31).
REFERENCES:
Grandgenett et al., (1978) Virology, 89:119-132.
Lillehoj et al., (1988) J. Virol., 62:8, 3053-3058.
Steimer et al., (1986) J. Virol., 58(1):9-16.
Allan et al., (1987) Blood, 69(1):331-333.
Houghten et al., (1985) Proc. Natl. Acad. Sci. USA, 82:5131-5135.
Meyers et al., (1990) Human Retroviruses and AIDS 1990, pp. II-14-II-21.
Center for Disease Control, (1986) JAMA Jul. 4, 256(1):20-25.
Wang et al., (1986) Proc. Natl. Acad. Sci. USA, 83:6159-6163.
Palker et al., (1987) Proc. Natl. Acad. Sci. USA, 84:2479-2483.
Palker et al., (1988) Proc. Natl. Acad. Sci. USA, 85:1932-1936.
Norrby et al., (1987) Nature, 329:248-250.
Norrby et al., AIDS Res. Human Retroviruses, (1991) 279-284.
Broliden et al., J. Acquired Immune Deficiency Syndrome, (1991) 4:952-958.
Goudsmit et al., (1989) J. AIDS, 2:297-302.
Kyte et al., (1982) J. Mol. Biol., 157:105-132.
Chou et al., (1978) Adv. Enzymol., 47:45-148.
Kopchick et al., (1981) J. Virol., 37:274-283.
Panet et al., (1975) Proc. Natl. Acad. Sci., 72:2535-2539.
Panganiban et al., (1984) Proc. Natl. Acad. Sci. USA, 81:7885-7889.
Donehower et al., (1984) Proc. Natl. Acad. Sci. USA, 81:6461-6465.
Tam et al., (1983) J. Am. Chem. Soc., 105:6442-6455.
Houghten et al., (1986) Int. J. Pept. Protein Res., 27:673-678.
Cashion Jr. Merrell C.
Celsa Bennett
LandOfFree
Polypeptides derived from the human immunodeficiency virus endon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptides derived from the human immunodeficiency virus endon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides derived from the human immunodeficiency virus endon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1760512